CeloNova BioSciences: Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv
12/2/2009 8:28:24 AM
More...
|
CeloNova BioSciences: Minimally Invasive Device Approved to Treat Liver Cancer, Fibroids, Tumors, and Bleeding
10/14/2009 8:59:35 AM
More...
|
CeloNova BioSciences: Scientific Paper Supports Micro-Bland Embolization Technique for Liver Cancer With Embozene(TM) Microspheres
10/6/2009 10:52:37 AM
More...
|
New Embolization Technique Using CeloNova BioSciences's Embozene(TM) Color-Advanced Microspheres Offers Better Clinical Outcomes In The Treatment Of Liver Cancer, European Institute of Oncology (EIO) Study
10/6/2009 7:50:52 AM
More...
|
CeloNova BioSciences: New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal
9/17/2009 9:45:14 AM
More...
|
CeloNova BioSciences Release: First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform New Color-Coded Embolic with Polyzene(R)-F Coating Enhances Procedural Safety, Efficiency during Treatment of Hypervascularized Tumors and Arteriovenous Malformations
1/2/2009 10:29:06 AM
More...
|
CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
12/16/2008 6:44:18 AM
More...
|
CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East
12/4/2008 9:11:24 AM
More...
|
CeloNova BioSciences Release: 12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
10/13/2008 10:30:00 AM
More...
|
CeloNova BioSciences Reports Yokohama Hospital Research Shows New Class Of Stent Effective In Preventing Thrombosis, Restenosis, And Reocclusion
10/2/2008 9:02:37 AM
More...
|
|